Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease

P A Yates1, R Sirisriro, V L Villemagne

  • 1Department of Nuclear Medicine and Centre for PET, Austin Health, 145 Studley Road, Heidelberg, Victoria 3084, Australia. paul.yates@austin.org.au

Neurology
|June 25, 2011
PubMed
Abstract

Insights

Asymptomatic beta-amyloid (Aβ) deposition in older adults is linked to lobar cerebral microhemorrhages (LMH). This finding suggests Aβ may play a role in microhemorrhage development even before cognitive decline.

Area of Science:

  • Neuroimaging
  • Neuropathology
  • Geriatric Medicine

Background:

  • Cerebral microhemorrhages (MH) are common in older adults, often detected via MRI.
  • MH have been associated with beta-amyloid (Aβ) deposition in Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA).

Purpose of the Study:

  • To investigate the association between Aβ deposition and lobar MH (LMH) in asymptomatic elderly individuals.
  • To determine if Aβ deposition predicts LMH in healthy older adults.

Main Methods:

  • Cross-sectional study involving healthy controls (HC), mild cognitive impairment (MCI), and probable AD subjects.
  • Utilized 3-Tesla susceptibility-weighted MRI (SWI) for MH detection and (11)C-Pittsburgh compound B (PiB) PET for Aβ deposition quantification.
  • MH were manually counted and categorized; Aβ cortical binding was quantified as standardized uptake value ratio (SUVR).

Main Results:

  • Lobar MH (LMH) prevalence was observed across all groups, including HC.
  • PiB-positive (PiB+) subjects showed similar LMH prevalence regardless of clinical status.
  • In HC, LMH presence correlated positively with neocortical Aβ deposition (SUVR) and age.
  • PiB+ status and age independently predicted LMH occurrence in HC.

Conclusions:

  • Asymptomatic Aβ deposition in older adults is strongly associated with LMH.
  • This suggests a potential role for Aβ in the development of microhemorrhages, even in the absence of clinical symptoms.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...